Literature DB >> 23204698

Most breast cancer screening trials have a flawed design.

Nishant Gurnani1, Anurag Srivastava.   

Abstract

In the present article, we discuss that why most breast cancer screening trials have a flawed origin. We suggest some solutions to correct these flaws so that more valid and reliable screening trials can be conducted in the future.

Entities:  

Keywords:  Bias; Breast cancer; Mammography; Quality of life; Screening trials

Year:  2011        PMID： 23204698      PMCID： PMC3236276          DOI： 10.1007/s12262-011-0342-2

Source DB:  PubMed          Journal:  Indian J Surg        ISSN： 0973-9793            Impact factor:   0.656


  15 in total

Review 1.  Oncologists should measure life, not death: a newer perspective of cancer statistics.

Authors:  A Srivastava; A Sood
Journal:  Indian J Cancer       Date:  2009 Jan-Mar       Impact factor: 1.224

2.  Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-24       Impact factor: 79.321

3.  Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.

Authors:  M H Gail; L A Brinton; D P Byar; D K Corle; S B Green; C Schairer; J J Mulvihill
Journal:  J Natl Cancer Inst       Date:  1989-12-20       Impact factor: 13.506

4.  The Canadian National Breast Screening Study: a perspective on criticisms.

Authors:  C J Baines
Journal:  Ann Intern Med       Date:  1994-02-15       Impact factor: 25.391

5.  Should routine screening by mammography be replaced by a more selective service of risk assessment/risk management?

Authors:  Michael Baum
Journal:  Womens Health (Lond)       Date:  2010-01

6.  Overdiagnosis in screening: is the increase in breast cancer incidence rates a cause for concern?

Authors:  E Paci; J Warwick; P Falini; S W Duffy
Journal:  J Med Screen       Date:  2004       Impact factor: 2.136

7.  Family history, age, and risk of breast cancer. Prospective data from the Nurses' Health Study.

Authors:  G A Colditz; W C Willett; D J Hunter; M J Stampfer; J E Manson; C H Hennekens; B A Rosner
Journal:  JAMA       Date:  1993-07-21       Impact factor: 56.272

8.  Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study.

Authors:  Per-Henrik Zahl; Bjørn Heine Strand; Jan Maehlen
Journal:  BMJ       Date:  2004-03-10

9.  Statistical issues in randomized trials of cancer screening.

Authors:  Stuart G Baker; Barnett S Kramer; Philip C Prorok
Journal:  BMC Med Res Methodol       Date:  2002-09-19       Impact factor: 4.615

10.  Overdiagnosis of breast cancer in Denmark.

Authors:  P-H Zahl
Journal:  Br J Cancer       Date:  2004-04-19       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.